Greenwich LifeSciences, Inc. (GLSI)
USD 12.28
(-5.61%)
USD 12.28
(-5.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.47 Million | -6.2 Million | -4.29 Million | -1.15 Million | -293.26 Thousand | -114.95 Thousand |
| Net Income | -8.89 Million | -7.82 Million | -4.57 Million | -1.86 Million | -3.42 Million | -1.68 Million |
| Depreciation & Amortization | 3612.00 | 3612.00 | 3612.00 | 3609.00 | 3607.00 | 3607.00 |
| Deferred income taxes | -35.47 Thousand | -1.75 Million | -1.19 Million | -777.75 Thousand | - | - |
| Stock-based compensation | 2.37 Million | 1.74 Million | 660.58 Thousand | 677.98 Thousand | 194.94 Thousand | - |
| Change in working capital | 31.5 Thousand | -122.26 Thousand | -385.16 Thousand | 28.4 Thousand | 2.93 Million | 1.57 Million |
| Other non-cash items | 35.47 Thousand | 1.75 Million | 1.19 Million | 777.75 Thousand | -2.00 | -73.75 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | -7.53 Million | 2.83 Million | 29.8 Million | 215 Thousand | 200 Thousand |
| Debt repayment | - | - | - | -360 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -7.53 Million | - | - | - | - |
| Common Stock Issuance | - | - | 3.11 Million | 30.16 Million | - | 100 Thousand |
| Other Financing Activities | - | -7536.22 | -275.15 Thousand | -360 Thousand | 215 Thousand | 200 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 35.47 Thousand | - | -526.73 Thousand | -92.55 Thousand | 393.4 Thousand | 80.96 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3971.00 | -122.26 Thousand | 141.56 Thousand | 120.95 Thousand | 2.54 Million | 1.49 Million |
| Cash at beginning of period | 13.46 Million | 27.2 Million | 28.66 Million | 6835.00 | 85.1 Thousand | 54.00 |
| Cash at end of period | 6.98 Million | 13.46 Million | 27.2 Million | 28.66 Million | 6835.00 | 85.1 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.47 Million | -13.73 Million | -1.45 Million | 28.65 Million | -78.26 Thousand | 85.04 Thousand |
| Free Cash Flow | -6.47 Million | -6.2 Million | -4.29 Million | -1.15 Million | -293.26 Thousand | -114.95 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.6 Million | -2.47 Million | -2.74 Million | -8.89 Million | -2.39 Million | -1.62 Million |
| Depreciation & Amortization | 903.00 | 903.00 | 903.00 | 3612.00 | 903.00 | 903.00 |
| Deferred income taxes | - | - | -570.91 Thousand | -35.47 Thousand | -596.32 Thousand | -596.32 Thousand |
| Stock-based compensation | 594.52 Thousand | 594.52 Thousand | 594.52 Thousand | 2.37 Million | 594.52 Thousand | 594.52 Thousand |
| Change in working capital | 963.41 Thousand | 95.2 Thousand | -2881.00 | 31.5 Thousand | -4259.00 | 65.97 Thousand |
| Other non-cash items | -392.32 Thousand | 506.06 Thousand | 570.91 Thousand | 35.47 Thousand | 596.32 Thousand | 596.32 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.76 Million | 299.11 Thousand | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.76 Million | 299.11 Thousand | - | - | - | - |
| Other Financing Activities | 2.76 Million | 299.11 Thousand | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 988.64 Thousand | 90.26 Thousand | 25.41 Thousand | 35.47 Thousand | -69.56 Thousand | 79.61 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -25.23 Thousand | 4940.00 | -28.29 Thousand | -3971.00 | 65.3 Thousand | 65.97 Thousand |
| Cash at beginning of period | 5.5 Million | 6.98 Million | 9.14 Million | 13.46 Million | 10.94 Million | 11.91 Million |
| Cash at end of period | 7.22 Million | 5.5 Million | 6.98 Million | 6.98 Million | 9.14 Million | 10.94 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.71 Million | -1.48 Million | -2.15 Million | -6.47 Million | -1.8 Million | -966.97 Thousand |
| Free Cash Flow | -1.04 Million | -1.78 Million | -2.15 Million | -6.47 Million | -1.8 Million | -966.97 Thousand |
3708
SFTC
JUPITERIN
SADBHAV
KRNT
688557